Anicells’ mission is to accelerate and facilitate the go-to-patient process of novel cell therapy products by providing:
Regulatory Support
Assistance in the regulatory requirements for filing your product to the authorities
Development on Demand
GMP translation of the
cell therapy process
GMP Manufacturing
Production of the cell therapy product for clinical trials
Next Generation Process Development
Cell therapy process review and design for upscaling, outscaling and lean manufacturing
Today, cell therapy is at the forefront of development. Using living cells from a patient or healthy donor as medicine has the potential to improve
Anicells will attend the ‘Advanced Therapies’ conference on 24 and 25 May in London. We look forward to meeting ATMP players from across the world
Anicells was op nationale televisie! Aanleiding was een bijzondere prestatie van het anicells team. Als eerste in Vlaanderen produceerden zij CAR-T cellen voor de behandeling
